Skip to main content
SpringerLink
Log in

Prognostic assessment of coronary artery disease by exercise radionuclide ventriculography

  • Chapter
Book cover Cardiovascular Nuclear Medicine and MRI

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 128))

  • 76 Accesses

Summary

Exercise radionuclide angiography appears to contribute additional prognostic information to catheterisation and clinical data. Probably, the most important predictor of all-cause cardiovascular mortality is exercise radio nuclide left ventricular ejection fraction. The prognostic value of exercise radionuclide ventriculography may be enhanced when performed on medical therapy, since an abnormal ejection fraction response to exercise despite antiischemic medications identifies the high-risk patient. For postthrombolytic patients the logistically optimum time for routine testing may be 6-8 weeks postinfarction and not much later to avoid missing the high-risk patient. In treated patients with silent ischemia, exercise radionuclide ventriculography may offer a simple means of individualizing and optimalizing such treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Jones R. H., Floyd R. D., Austin E. H., Sabiston D. C. Jr. The role of radionuclide angiocardiography in the preoperative prediction of pain relief and prolonged survival following coronary artery bypass grafting. Ann Surg 1983;197:743–54.

    Article  PubMed  CAS  Google Scholar 

  2. Bonow R. O., Kent K. M., Rosing D. R., et al. Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy. N Engl J Med 1984;311:1339–45.

    Article  PubMed  CAS  Google Scholar 

  3. Pryor D. B., Harrell F. E. Jr, Lee K. L., et al. Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol 1984;53:18–22.

    Article  PubMed  CAS  Google Scholar 

  4. Iskandrian A. S., Hakki A. H., Schwarz J. S., Kay H., Mattleman S., Kane S., Prognostic implications of rest and exercise radionuclide ventriculography in patients with suspected or proven coronary heart disease. Int J Cardiol 1984;6:707–18.

    Article  PubMed  CAS  Google Scholar 

  5. Gibbons R. J., Fyke F. E., Clements I. P., Lapeyre A. C, Zinsmeister A. R., Brown M. L. Noninvasive identification of severe coronary artery disease using exercise radionuclide angiography. J Am Coll Cardiol 1988;11:28–34.

    Article  PubMed  CAS  Google Scholar 

  6. Miller T. D., Taliercio C. P., Zinsmeister A. R., Gibbons R. J., Risk stratification of single or double vessel coronary artery disease and impaired left ventricular function using exercise radionuclide angiography. Am J Cardiol 1990;65:1317–21.

    Article  PubMed  CAS  Google Scholar 

  7. Lee K. L, Pryor D. B., Pieper K. S, et al. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables. Circulation 1990;82:1705–17.

    Article  PubMed  CAS  Google Scholar 

  8. Morris K. G., Palmeri S. T., Califf R. M., et al. Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction. Am J Cardiol 1985;55:318–24.

    Article  PubMed  CAS  Google Scholar 

  9. Lim R., Dyke L., Dymond D. S., Prognostic importance of failure of medical therapy to normalise exercise ejection fraction response in coronary artery disease (abstract). J Am Coli Cardiol 1991;17 Suppl A:183A.

    Google Scholar 

  10. Schaer D. H., Ross A. M., Wasserman A. G. Reinfarction, recurrent angina, and reocc1usion after thrombolytic therapy. Circulation 1987;76 (2 Pt 2):1157–62.

    Google Scholar 

  11. Califf R. M., Harrelson-Woodlief L., Topol E. J. Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials. Circulation 1990;82:1847–53.

    Article  PubMed  CAS  Google Scholar 

  12. Simoons M. L., Vos J., Tijssen J. G. P., et al. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. J Am Coli Cardiol 1989;14:1609–15.

    Article  CAS  Google Scholar 

  13. Corbett J. R., Dehmer G. J., Lewis S. E., et al. The prognostic value of submaximal exercise testing with radionuclide ventriculography prior to hospital discharge in patients with recent myocardial infarction. Circulation 1981;64:535–44.

    Article  PubMed  CAS  Google Scholar 

  14. Hung J., Goris M. L., Nash E., et al. Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and exercise radio nuclide ventriculography for distinguishing high-and low-risk patients soon after acute myocardial infarction. Am J Cardiol 1984;53:1221–7.

    Article  PubMed  CAS  Google Scholar 

  15. DeBusk R. F., Dennis C. A., ’submaximal’ predischarge exercise testing after acute myocardial infarction: who needs it? Am J Cardiol 1985;55:498–500.

    Google Scholar 

  16. SWIFT trial of delayed elective intervention vs conservative treatment after thrombolysiswith anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?). BMJ 1991;302:555–60.

    Article  Google Scholar 

  17. Simoons M. L., Arnold A. E., Betriu A., et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988;i:197–203.

    Article  Google Scholar 

  18. Rogers W. J., Baim D. S., Gore J. M., et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction Trial (TIMI) Phase I-A trial. Circulation 1990;81:1457–76.

    Article  PubMed  CAS  Google Scholar 

  19. Ellis S. G., Topol E. J., George B. S., et al. Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation 1989;80:1159–65.

    Article  PubMed  CAS  Google Scholar 

  20. ACC/ AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. Circulation 1990;82:664–707.

    Google Scholar 

  21. Ellis S. G., Henschke C. I., Sandor T., Wynne J., Braunwald E., Kloner R. A. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coli Cardiol 1983;1:1047–55.

    Google Scholar 

  22. Sheehan F. H., Doerr R., Schmidt W. G., et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. J Am Coli Cardiol 1988;12:289–300.

    Article  CAS  Google Scholar 

  23. Pfisterer M., Zuber M., Wenzel R., Burkart F. Prolonged myocardial stunning after thrombolysis: can left ventricular function be assessed definitely at hospital discharge? Eur Heart J 1991;12:214–17.

    PubMed  CAS  Google Scholar 

  24. Marzoll U., Kleiman N. S., Dunn J. K., et al. Factors determining improvement in left ventricular function after reperfusion therapy for acute myocardial infarction: primacy of baseline ejection fraction. J Am Coli Cardiol 1991;17:613–20.

    Article  CAS  Google Scholar 

  25. Weiner D. A., Ryan T. J., McCabe C. H., et al. Comparison of coronary artery bypass surgery and medical therapy in patients with exercise-induced silent myocardial ischemia: a report from the Coronary Artery Surgery Study (CASS) registry. J Am Coli Cardiol 1988;12:595–9.

    Google Scholar 

  26. Breitenbucher A., Pfisterer M., Hoffmann A., Burckhardt D. Long-term follow-up of patients with silent ischemia during exercise radionuclide angiography. J Am Coli Cardiol 1990;15:999–1003.

    Article  CAS  Google Scholar 

  27. Borer J. S., Bacharach S. L., Green M. V., Kent K. M., Johnston G. S., Epstein S. E., Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection fraction in coronary artery disease. Assessment by radionuclide cineangiography in symptomatic and asymptomatic patients. Circulation 1978;57:314–20.

    Article  PubMed  CAS  Google Scholar 

  28. Imperi G. A., Lambert C. R., Coy K., Lopez L., Pepine C. J. Effects of titrated beta-blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am J Cardiol 1987;60:519–24.

    Article  PubMed  CAS  Google Scholar 

  29. Mulcahy D., Keegan J., Cunningham D., et al. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 1988;ii:755–9.

    Article  Google Scholar 

  30. Van der Wall E. E., Manger Cats V., Blokland J. A. K., et al. The effects of diltiazem on cardiac function in silent ischemia after myocardial infarction. Am Heart J 1989;118:655–61.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Richard Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Duncan S. Dymond
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Diagnostic Radiology and Nuclear Medicine, University Hospital Leiden, Leiden, The Netherlands

    Johan H. C. Reiber

  2. Department of Cardiology, University Hospital Leiden, Leiden, The Netherlands

    Ernst E. Van Der Wall

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Lim, R., Dymond, D.S. (1992). Prognostic assessment of coronary artery disease by exercise radionuclide ventriculography. In: Reiber, J.H.C., Van Der Wall, E.E. (eds) Cardiovascular Nuclear Medicine and MRI. Developments in Cardiovascular Medicine, vol 128. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2666-3_19

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-2666-3_19

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5179-8

  • Online ISBN: 978-94-011-2666-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation